Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07084363 · ClinicalTrials.gov registry record · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
A NA study of Neuromuscular Block, Residual, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 1,032
- Enrollment target
- 1
- Study location
NCT07084363: Recruiting NA study of Neuromuscular Block, Residual, sponsored by The University of Texas Health Science Center, Houston.
NCT07084363 is a NA study of Neuromuscular Block, Residual that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,032 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07084363, a NA study of Neuromuscular Block, Residual, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,032 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effect of quantitative block monitoring versus less expensive qualitative monitoring treatment effects on the lowest SpO2/FiO2 ratio in the PACU. The results will be incorporated into an enhanced recovery pathway for surgical patients.
Conditions Studied
Interventions
- DEVICE Quantitative monitoring
- OTHER Qualitative monitoring
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,032 participants |
| Start Date | 2025-09-22 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
What NCT07084363 shows while recruiting
NCT07084363 is an interventional study that assigns participants to a tested intervention. Its 1,032 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Neuromuscular Block, Residual appearing as the primary indexed condition, and to 2 interventions - of which Quantitative monitoring is the first listed.
NCT07084363 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07084363 about?
NCT07084363 is a clinical study titled "Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery". The purpose of this study is to assess the effect of quantitative block monitoring versus less expensive qualitative monitoring treatment effects on the lowest SpO2/FiO2 ratio in the PACU. The results will be incorporated into an enhanced recovery pathway for surgical patients.
What is the current status of trial NCT07084363?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,032 participants. The study started on 2025-09-22. Estimated completion is 2026-04-01.
What conditions does trial NCT07084363 study?
This clinical trial studies the following conditions: Neuromuscular Block, Residual.
What interventions are being tested in trial NCT07084363?
The interventions under investigation include: Quantitative monitoring (DEVICE), Qualitative monitoring (OTHER).
Who is sponsoring clinical trial NCT07084363?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07084363 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07084363's enrollment target sits among peer trials
1,032 103rd of 2000 higher than 1,898 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06080698 · 1,030 participants · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
- NCT05037682 · 1,035 participants · NA
Pain and Opioid Management in Older Adults
- NCT07282600 · 1,035 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- NCT07345767 · 1,038 participants · NA
Hypknowledge Nationwide Sleep Extension
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI